공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 담관암 시장(2021-2028년)

Global Bile Duct Cancer Market - 2021-2028

리서치사 DataM Intelligence
발행일 On Demand Report 상품 코드 1008251
페이지 정보 영문 180 Pages
가격
US $ 4,350 ₩ 5,149,000 PDF & Excel (Single User License)
US $ 4,850 ₩ 5,741,000 PDF & Excel (Multiple User License)
US $ 7,850 ₩ 9,292,000 PDF & Excel (Enterprise License)


세계의 담관암 시장(2021-2028년) Global Bile Duct Cancer Market - 2021-2028
발행일 : On Demand Report 페이지 정보 : 영문 180 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

담관암은 담관의 안에 암세포가 생기는 희귀한 질병입니다. 대장염이나 특정 간질환이 있으면 담관암의 위험이 배증합니다. 담관암 징조로는 황달과 복부 통증이 있습니다. 담관암 시장은 세계적인 담관암 환자수 증가와 의료 분야의 기술 진보, 선진국의 의료비 증가 등에 의해 성장이 촉진되고 있습니다.

세계의 담관암(Bile Duct Cancer) 시장을 조사했으며, 시장 개요, 부문·지역별 시장 규모 및 성장률 추정과 예측, 신종 코로나바이러스 감염증(COVID-19)의 영향 분석, 시장 성장 촉진요인 및 억제요인 분석, 시장 기회, 가격 및 무역 동향, 경쟁 상황, 주요 기업 개요 등을 정리했습니다.

목차

제1장 조사 방법과 범위

  • 조사 방법
  • 조사 목적과 조사 범위

제2장 시장 정의와 개요

제3장 주요 요약

  • 시장 내역 : 종류별
  • 시장 내역 : 치료법별
  • 시장 내역 : 진단법별
  • 시장 내역 : 최종사용자별
  • 시장 내역 : 지역별

제4장 시장 역학

  • 시장 영향요인
    • 성장 촉진요인
    • 성장 억제요인
    • 시장 기회
    • 영향 분석

제5장 업계 분석

  • Porter's Five Forces 분석
  • 공급망 분석
  • 가격 분석
  • 규제 분석
  • 상환 분석
  • 미충족 수요

제6장 신종 코로나바이러스 감염증(COVID-19)의 영향 분석

  • 신종 코로나바이러스 감염증(COVID-19)의 영향 분석
    • 코로나 이전 시장 시나리오
    • 현재 시장 시나리오
    • 코로나 이후 시장 시나리오
  • 코로나 동안 가격 동향
  • 수급 스펙트럼
  • 코로나 동안 시장에 대한 정부 정책
  • 제조업체의 전략적 이니셔티브
  • 결론

제7장 세계의 담관암 시장 : 종류별

  • 서론
    • 시장 규모·전년대비 성장률 분석 : 종류별
    • 시장 매력 지수 : 종류별
  • 간내 담관암
    • 서론
    • 시장 규모·성장률 분석
  • 간외 담관암

제8장 세계의 담관암 시장 : 치료법별

  • 서론
    • 시장 규모·전년대비 성장률 분석 : 치료법별
    • 시장 매력 지수 : 치료법별
  • 표적요법
    • 서론
    • 시장 규모·성장률 분석
  • 면역요법
  • 방사선 치료
  • 화학요법

제9장 세계의 담관암 시장 : 진단법별

  • 서론
    • 시장 규모·전년대비 성장률 분석 : 진단법별
    • 시장 매력 지수 : 진단법별
  • 혈액 검사
    • 서론
    • 시장 규모·성장률 분석
  • 복부 이미징
  • 수술
  • MRI
  • 기타

제10장 세계의 담관암 시장 : 최종사용자별

  • 서론
    • 시장 규모·전년대비 성장률 분석 : 최종사용자별
    • 시장 매력 지수 : 최종사용자별
  • 병원
    • 서론
    • 시장 규모·성장률 분석
  • 진료소
  • 외래 외과 센터

제11장 세계의 담관암 시장 : 지역별

  • 서론
    • 시장 규모 분석·전년대비 성장률 : 지역별
    • 시장 매력 지수 : 지역별
  • 북미
    • 서론
    • 시장 역학
    • 시장 규모·전년대비 성장률 : 종류별
    • 시장 규모·전년대비 성장률 : 치료별
    • 시장 규모·전년대비 성장률 : 진단법
    • 시장 규모·전년대비 성장률 : 최종사용자별
    • 시장 규모·전년대비 성장률 : 국가별
  • 유럽
    • 서론
    • 시장 역학
    • 시장 규모·전년대비 성장률 : 종류별
    • 시장 규모·전년대비 성장률 : 치료별
    • 시장 규모·전년대비 성장률 : 진단법
    • 시장 규모·전년대비 성장률 : 최종사용자별
    • 시장 규모·전년대비 성장률 : 국가별
  • 남미
    • 서론
    • 시장 역학
    • 시장 규모·전년대비 성장률 : 종류별
    • 시장 규모·전년대비 성장률 : 치료별
    • 시장 규모·전년대비 성장률 : 진단법
    • 시장 규모·전년대비 성장률 : 최종사용자별
    • 시장 규모·전년대비 성장률 : 국가별
  • 아시아태평양
    • 서론
    • 시장 역학
    • 시장 규모·전년대비 성장률 : 종류별
    • 시장 규모·전년대비 성장률 : 치료별
    • 시장 규모·전년대비 성장률 : 진단법
    • 시장 규모·전년대비 성장률 : 최종사용자별
    • 시장 규모·전년대비 성장률 : 국가별
  • 중동 및 아프리카
    • 서론
    • 시장 역학
    • 시장 규모·전년대비 성장률 : 종류별
    • 시장 규모·전년대비 성장률 : 치료별
    • 시장 규모·전년대비 성장률 : 진단법
    • 시장 규모·전년대비 성장률 : 최종사용자별

제12장 경쟁 상황

  • 주요 전략·발전 동향
  • 기업 점유율 분석
  • 제품 벤치마크

제13장 기업 개요

  • Johnson & Johnson
    • 기업 개요
    • 제품 포트폴리오
    • 주요 하이라이트
    • 재무 상황
  • Bayer AG
  • Celgene Corp
  • Bristol-Myers Squibb
  • Pfizer, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Sanofi
  • Novartis AG
  • Merck & Co., Inc.,
  • Boston Scientific Corporation

제14장 DataM Intelligence 소개

KSM 21.06.29

Market Overview

The global bile duct cancer market size was valued US$ XX billion in 2020 and is estimated to reach US$ XX billion by 2028, growing at a CAGR of XX % during the forecast period (2021-2028).

Bile duct cancer is an uncommon disorder in which cancer cells form in the bile ducts. Having colitis or specific liver diseases can double the risk of bile duct cancer. Signs of bile duct cancer involve jaundice and pain in the abdomen. Bile duct cancer, also known as cholangiocarcinomas, begins in a bile duct.

Market Dynamics

The bile duct cancer market growth is driven by increase in the prevalence of bile duct cancer patients across the globe, technological advancement in the health care sector, and a rise in health care expenditure across the globe.

Increasing prevalence and incidence of cancer worldwide in the elderly population

As per the NCBI, in 2014, an estimated 66,771 people lived with bile duct cancer in the U.S. Moreover, the disease is exacted to cause 28,920 deaths at the end of 2017, estimating 4.8% of all cancer deaths. Rates for new intrahepatic bile duct cancer cases have grown by an average of 2.7% each year across the last ten years. Death rates have been estimated to have increased by an average of 2.6% each year over 2005-2014 and the same is expected to be seen in the year from 2018-2030. Such a rise in the prevalence of bile duct cancer has driven the growth of the market.

The increasing prevalence of diseases such as liver fluke will significantly escalate the demand for bile duct cancer treatment in healthcare institutions. Such factors are likely to positively impact the global bile duct cancer market's growth during the forecast period. Moreover, increasing exposure to harmful chemicals for printing and other applications is affecting the industrial workers adversely. Due to such factors, bile duct cancer treatment is likely to increase demand across various healthcare industries.

Rising modern diagnostic facilities for the detection of bile duct cancer is driving the market growth

A precise and detailed bile duct cancer diagnosis is the first step in devising a bile duct cancer treatment. Several lab tests are available to check for abnormalities in the bile duct, including blood counts of bilirubin, albumin, alkaline phosphatase, aspartate transaminase (AST), alanine transaminase (ALT) and gamma-glutamyl transpeptidase (GGT). High levels of these elements in the blood indicate problems with the bile duct, gallbladder or liver.

Endoscopic ultrasound may help the doctor see more precise pictures of the bile duct. A thin, glowing tube with a small video camera is inserted through the mouth and esophagus into the small intestines near the bile duct. In rare cases, a laparoscopic ultrasound, through small holes in the front of the abdomen, may be used to check the bile duct and other internal organs. Thus, an increasing focus on these lab tests for treating the infection drives the market growth in the forecast period.

Side effects associated with medications coupled with high cost of cancer treatment

Side-effects such as radiation therapy can bring hair loss (sometimes called alopecia) to the part of the body receiving radiation. At the same time, chemotherapy can lead to hair loss in the head, scalp, and other body parts. Various chemotherapy medications can cause several types of hair loss or no hair loss at all. Hair loss usually happens within two weeks of treatment, worsening over the first month or two of ongoing treatment.

The American Society of Clinical Oncology states that there is a yawning gap between cancer treatment costs in the developed and developing countries. Moreover, the US, importing prescription medicines from the foreign countries is not allowed. Also, Patented Medicine Prices Review Board of the government of Canada states that people in the US end up paying more than 100% than any of their counterparts for patented drugs. These variations in prices are likely to hinder the bile duct cancer treatment market.

COVID-19 Impact Analysis

COVID-19 pandemic on bile duct cancer care decreased, and delays in identifying new bile duct cancers and treatment delivery. These problems, if unmitigated, will increase cancer morbidity and mortality in the forecast period. While the immediate care and access disruptions associated with the COVID-19 pandemic have received growing attention in certain areas, the full range of cancer screenings and treatment gaps is not yet well understood or well documented throughout the world comprehensively.

Many healthcare providers accommodated short-term adjustments to cancer care delivery, such as temporarily discontinuing nonemergent cancer screenings, shifting the delivery of care and delaying surgeries and other in-office cancer services to reduce transmission risk, build hospital capacity in anticipation of increasing rates of coronavirus infections, and comply with state regulations and guidelines from the CDC.

Segment Analysis

Intrahepatic bile duct cancer segment is expected to grow at the fastest CAGR during the forecast period (2021-2028)

Intrahepatic bile duct cancer is a rare type of cancer. It begins in the small bile duct sections that carry bile inside the liver. Only about 5 to 10 percent of bile duct cancers are categorized as intrahepatic, and some are misdiagnosed as liver cancer.

The expanse of a patient's intrahepatic bile duct cancer will affect how it is treated, amongst other factors like age and overall health. Patients with early-stage malignancies often have resection surgery to remove the altered bile duct and encompass lymph nodes. Radiation therapy and chemotherapy may also be used to attack cancer cells. Some later-stage bile duct cancers may not be surgically detachable, in which case a combination of radiation therapy, chemotherapy and radiofrequency ablation may be used to decrease symptoms.

Extrahepatic bile duct cancer is a rare disease in which dangerous cancer cells form in the bile duct outside the liver. Various types of therapy are available for patients with extrahepatic bile duct cancer. Some procedures are standard, and some are being tested in clinical trials. When clinical trials confirm that a new treatment is more valuable than the standard treatment, the new treatment may become the standard treatment. Patients may want to think about taking part in a clinical trial. Some clinical trials are open only to patients who have not started treatment.

The chemotherapy segment are expected to dominate the bile duct cancer market during the forecast period

Chemotherapy is the use of anti-cancer medications used to treatment of cancerous cells. Chemotherapy has been done for many years and is one of the most prevalent cancer treatments. In most instances, chemotherapy works by preventing the cancer cell's ability to grow or multiply. Several groups of medications work in many ways to fight cancer cells. Chemotherapy may be used alone for some types of cancer or in sequence with other treatments such as radiation or surgery. Often, a mixture of chemotherapy drugs is used to fight particular cancer. Some chemotherapy drugs are given in a specific amount depending on the type of cancer used for treatment.

While chemotherapy can be quite efficient in treating specific cancers, chemotherapy medications reach all body parts. The carcinoma cells that cause may be many side effects during therapy.

Geographical Analysis

North America region holds the largest market share in the global Bile Duct Cancer Market

North America region is dominating the global bile duct cancer market accounted for the largest market share in 2020, owing to the presence of a robust healthcare infrastructure that supports innovations. Also, general awareness among people about personal health is more significant than in other regions of the world. Most novel technology, be that diagnostic or therapeutic, comes from these regions. Also, an increasing geriatric population here helps growth in this market.

Competitive Landscape

The bile duct cancer market is moderately competitive with presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Johnson & Johnson, Bayer AG, Celgene Corp, Bristol-Myers Squibb, Pfizer, Inc., F. Hoffmann-La Roche Ltd., Sanofi, Novartis AG, Merck & Co., Inc., ConMed Corporation, and Boston Scientific Corporation among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the bile duct cancer market globally.

Key Companies to Watch

Pfizer Inc.

Overview: Pfizer Inc. (Pfizer), is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines. The Company sold its products in over 125 countries.

Product Portfolio: The Company's portfolio comprised of include internal medicine, vaccines, oncology, inflammation and immunology and rare diseases and others.

Why Purchase the Report?

  • Visualize the composition of the bile duct cancer market segmentation by type, treatment, and end user highlighting the key commercial assets and players.
  • Identify commercial opportunities in bile duct cancer market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of bile duct cancer market - level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The global bile duct cancer market report would provide an access to an approximately 45+ market data table, 40+ figures and 180 pages.

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Market Segmentation

Global Bile Duct Cancer Treatment Market - By Type

  • Intrahepatic Bile Duct Cancer
  • Extrahepatic Bile Duct Cancer

Global Bile Duct Cancer Treatment Market - By Treatment

  • Diagnosis

Blood Tests

Abdominal Imaging

MRI

Others

  • Therapy

Targeted Therapy

Immunotherapy

Radiation Therapy

Chemotherapy

Global Bile Duct Cancer Market - By End User

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers

Global Bile Duct Cancer Market - By Region

  • North America
  • South America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Table of Contents

1. Global Bile Duct Cancer Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Bile Duct Cancer Market - Market Definition and Overview

3. Global Bile Duct Cancer Market - Executive Summary

  • 3.1. Market Snippet by Type
  • 3.2. Market Snippet by Treatment
  • 3.3. Market Snippet by End User
  • 3.4. Market Snippet by Region

4. Global Bile Duct Cancer Market - Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising modern diagnostic facilities for the detection of bile duct cancer is driving the market growth
      • 4.1.1.2. Increasing prevalence and incidence of cancer worldwide in the elderly population
    • 4.1.2. Restraints:
      • 4.1.2.1. Side effects associated with medications coupled with high cost of cancer treatment
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global Bile Duct Cancer Market - Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Reimbursement Analysis
  • 5.6. Unmet Needs

6. Global Bile Duct Cancer Market - COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Global Bile Duct Cancer Market - By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type Segment
    • 7.1.2. Market Attractiveness Index, By Type Segment
  • 7.2. Intrahepatic Bile Duct Cancer*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 7.3. Extrahepatic Bile Duct Cancer

8. Global Bile Duct Cancer Market - By Treatment

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment
    • 8.1.2. Market Attractiveness Index, By Treatment
  • 8.2. Therapy*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
    • 8.2.3. Targeted Therapy
    • 8.2.4. Immunotherapy
    • 8.2.5. Radiation Therapy
    • 8.2.6. Chemotherapy
  • 8.3. Diagnosis
    • 8.3.1. Blood Tests
    • 8.3.2. Abdominal Imaging
    • 8.3.3. MRI
    • 8.3.4. Others

9. Global Bile Duct Cancer Market - By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
    • 9.1.2. Market Attractiveness Index, By End User Segment
  • 9.2. Hospitals *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 9.3. Clinics
  • 9.4. Ambulatory Surgical Centers

10. Global Bile Duct Cancer Market - By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

11. Global Bile Duct Cancer Market - Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Product Benchmarking
  • 11.4. List of key companies to watch
  • 11.5. List of the company with disruptive technology
  • 11.6. List of start-up companies

12. Global Bile Duct Cancer Market- Company Profiles

  • 12.1. Johnson & Johnson *
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Bayer AG
  • 12.3. Celgene Corp
  • 12.4. Bristol-Myers Squibb
  • 12.5. Pfizer, Inc.
  • 12.6. F. Hoffmann-La Roche Ltd.
  • 12.7. Sanofi
  • 12.8. Novartis AG
  • 12.9. Merck & Co., Inc.,
  • 12.10. Boston Scientific Corporation

LIST NOT EXHAUSTIVE

13. Global Bile Duct Cancer Market - DataM

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us
Back to Top
전화 문의
F A Q